Bio Protocol completed a $6.9 million seed round financing, led by Arthur Hayes' Maelstrom Fund.

robot
Abstract generation in progress

On September 17, Bio Protocol completed a $6.9 million seed round of financing, led by Arthur Hayes's Maelstrom Fund. Companies such as Mechanism Capital, Animoca Brands, Zee Prime Capital, Panga Capital, Mirana Ventures, Foresight Ventures, and Big Brain Holdings participated in the financing. Bio Protocol will launch an AI-based Decentralization science platform for biotechnology financing and drug discovery. This financing coincides with the launch of Bio V2, which introduces on-chain fundraising and a Decentralization AI-driven framework for early-stage scientific research and development. Researchers, patients, and the encryption community can use BioAgents to generate scientific hypotheses, monetize discoveries, and more quickly uncover hidden insights in the field of biology, going beyond traditional biotechnology.

BIO0.85%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)